{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T15:54:33Z","timestamp":1783698873849,"version":"3.55.0"},"reference-count":181,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1038\/s41585-021-00562-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T12:14:23Z","timestamp":1643717663000},"page":"240-252","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Galectins as potential therapeutic targets in STIs in the female genital tract"],"prefix":"10.1038","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4906-6951","authenticated-orcid":false,"given":"Agustin L.","family":"Lujan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8623-0645","authenticated-orcid":false,"given":"Diego O.","family":"Croci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0947-8735","authenticated-orcid":false,"given":"Gabriel A.","family":"Rabinovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0145-4402","authenticated-orcid":false,"given":"Maria T.","family":"Damiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"562_CR1","unstructured":"WHO. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Accountability for the global health sector strategies 2016\u20132021: actions for impact (WHO, 2021). This WHO report provides data about the effect, strategies, progress, actions and remaining challenges to achieving effective intervention in STIs and universal health coverage."},{"key":"562_CR2","unstructured":"Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2019 (2021)."},{"key":"562_CR3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ypmed.2017.12.018","volume":"107","author":"CH Logie","year":"2018","unstructured":"Logie, C. H. et al. HIV-related stigma, racial discrimination, and gender discrimination: pathways to physical and mental health-related quality of life among a national cohort of women living with HIV. Prev. Med. 107, 36\u201344 (2018).","journal-title":"Prev. Med."},{"key":"562_CR4","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.18.6.20302","volume":"18","author":"A Amin","year":"2015","unstructured":"Amin, A. Addressing gender inequalities to improve the sexual and reproductive health and wellbeing of women living with HIV. J. Int. AIDS Soc. 18, 20302 (2015).","journal-title":"J. Int. AIDS Soc."},{"key":"562_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/OLQ.0000000000001380","volume":"48","author":"HW Chesson","year":"2021","unstructured":"Chesson, H. W. et al. The estimated direct lifetime medical costs of sexually transmitted infections acquired in the United States in 2018. Sex. Transm. Dis. 48, 215\u2013221 (2021).","journal-title":"Sex. Transm. Dis."},{"key":"562_CR6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1177\/0956462413481526","volume":"24","author":"V Minichiello","year":"2013","unstructured":"Minichiello, V., Rahman, S. & Hussain, R. Epidemiology of sexually transmitted infections in global indigenous populations: data availability and gaps. Int. J. STD AIDS 24, 759\u2013768 (2013).","journal-title":"Int. J. STD AIDS"},{"key":"562_CR7","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman, K. J. et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016\u201340 for 195 countries and territories. Lancet 392, 2052\u20132090 (2018).","journal-title":"Lancet"},{"key":"562_CR8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sextrans-2019-053972","volume":"96","author":"MJ Cole","year":"2020","unstructured":"Cole, M. J. et al. Substantial under diagnosis of lymphogranuloma venereum in men who have sex with men in Europe: preliminary findings from a multicentre surveillance pilot. Sex. Transm. Infect. 96, 137\u2013142 (2020).","journal-title":"Sex. Transm. Infect."},{"key":"562_CR9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1099\/mic.0.26905-0","volume":"150","author":"X Zhou","year":"2004","unstructured":"Zhou, X. et al. Characterization of vaginal microbial communities in adult healthy women using cultivation-independent methods. Microbiology 150, 2565\u20132573 (2004).","journal-title":"Microbiology"},{"key":"562_CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000321042","volume":"40","author":"MA Farage","year":"2011","unstructured":"Farage, M. A. & Maibach, H. I. Morphology and physiological changes of genital skin and mucosa. Curr. Probl. Dermatol. 40, 9\u201319 (2011).","journal-title":"Curr. Probl. Dermatol."},{"key":"562_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphys.2015.00081","volume":"6","author":"MI Petrova","year":"2015","unstructured":"Petrova, M. I., Lievens, E., Malik, S., Imholz, N. & Lebeer, S. Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front. Physiol. 6, 1\u201318 (2015).","journal-title":"Front. Physiol."},{"key":"562_CR12","doi-asserted-by":"crossref","first-page":"132ra52","DOI":"10.1126\/scitranslmed.3003605","volume":"4","author":"P Gajer","year":"2012","unstructured":"Gajer, P. et al. Temporal dynamics of the human vaginal microbiota. Sci. Transl. Med. 4, 132ra52 (2012).","journal-title":"Sci. Transl. Med."},{"key":"562_CR13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ymeth.2018.04.022","volume":"149","author":"P Pruski","year":"2018","unstructured":"Pruski, P. et al. Assessment of microbiota:host interactions at the vaginal mucosa interface. Methods 149, 74\u201384 (2018).","journal-title":"Methods"},{"key":"562_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21218266","volume":"21","author":"G Lacroix","year":"2020","unstructured":"Lacroix, G., Gouyer, V., Gottrand, F. & Desseyn, J. L. The cervico vaginal mucus barrier. Int. J. Mol. Sci. 21, 1\u201323 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"562_CR15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nrmicro2146","volume":"7","author":"GR Vasta","year":"2009","unstructured":"Vasta, G. R. Roles of galectins in infection. Nat. Rev. Microbiol. 7, 424\u2013438 (2009). This review provides an overview of the role of galectins in host\u2013pathogen interactions, immune recognition and subversion of immune responses.","journal-title":"Nat. Rev. Microbiol."},{"key":"562_CR16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2012.00199","volume":"3","author":"GR Vasta","year":"2012","unstructured":"Vasta, G. R. et al. Galectins as self\/non-self recognition receptors in innate and adaptive immunity: an unresolved paradox. Front. Immunol. 3, 1\u201314 (2012).","journal-title":"Front. Immunol."},{"key":"562_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/aji.12090","volume":"69","author":"AG Blidner","year":"2013","unstructured":"Blidner, A. G. & Rabinovich, G. A. \u2018Sweetening\u2019 pregnancy: galectins at the fetomaternal interface. Am. J. Reprod. Immunol. 69, 369\u2013382 (2013).","journal-title":"Am. J. Reprod. Immunol."},{"key":"562_CR18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.0105-2896.2005.00287.x","volume":"206","author":"CR Wira","year":"2005","unstructured":"Wira, C. R., Fahey, J. V., Sentman, C. L., Pioli, P. A. & Shen, L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol. Rev. 206, 306\u2013335 (2005).","journal-title":"Immunol. Rev."},{"key":"562_CR19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1074\/mcp.M600439-MCP200","volume":"6","author":"Y Andersch-Bj\u00f6rkman","year":"2007","unstructured":"Andersch-Bj\u00f6rkman, Y., Thomsson, K. A., Holm\u00e9n Larsson, J. M., Ekerhovd, E. & Hansson, G. C. Large scale identification of proteins, mucins, and their O-glycosylation in the endocervical mucus during the menstrual cycle. Mol. Cell. Proteom. 6, 708\u2013716 (2007).","journal-title":"Mol. Cell. Proteom."},{"key":"562_CR20","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.1000086107","volume":"108","author":"JM Macklaim","year":"2011","unstructured":"Macklaim, J. M., Gloor, G. B., Anukam, K. C., Cribby, S. & Reid, G. At the crossroads of vaginal health and disease, the genome sequence of Lactobacillus iners AB-1. Proc. Natl Acad. Sci. USA 108, 4688\u20134695 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0080074","volume":"8","author":"DE O\u2019Hanlon","year":"2013","unstructured":"O\u2019Hanlon, D. E., Moench, T. R. & Cone, R. A. Vaginal pH and microbicidal lactic acid when lactobacilli dominate the microbiota. PLoS ONE 8, 1\u20138 (2013).","journal-title":"PLoS ONE"},{"key":"562_CR22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nri3819","volume":"15","author":"CR Wira","year":"2015","unstructured":"Wira, C. R., Rodriguez-Garcia, M. & Patel, M. V. The role of sex hormones in immune protection of the female reproductive tract. Nat. Rev. Immunol. 15, 217\u2013230 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"562_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm.4142","volume":"22","author":"S Tamburini","year":"2016","unstructured":"Tamburini, S., Shen, N., Wu, H. C. & Clemente, J. C. The microbiome in early life: implications for health outcomes. Nat. Med. 22, 713\u2013722 (2016).","journal-title":"Nat. Med."},{"key":"562_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0153553","volume":"11","author":"P Mirmonsef","year":"2016","unstructured":"Mirmonsef, P. et al. Glycogen levels in undiluted genital fluid and their relationship to vaginal pH, estrogen, and progesterone. PLoS ONE 11, 1\u201310 (2016).","journal-title":"PLoS ONE"},{"key":"562_CR25","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1095\/biolreprod.105.043133","volume":"73","author":"J Pudney","year":"2005","unstructured":"Pudney, J., Quayle, A. J. & Anderson, D. J. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone. Biol. Reprod. 73, 1253\u20131263 (2005).","journal-title":"Biol. Reprod."},{"key":"562_CR26","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jri.2010.07.008","volume":"88","author":"LY Hwang","year":"2011","unstructured":"Hwang, L. Y., Scott, M. E., Ma, Y. & Moscicki, A.-B. Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J. Reprod. Immunol. 88, 66\u201371 (2011).","journal-title":"J. Reprod. Immunol."},{"key":"562_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/1476-9255-1-1","volume":"1","author":"NA Punchard","year":"2004","unstructured":"Punchard, N. A., Whelan, C. J. & Adcock, I. The journal of inflammation. J. Inflamm. 1, 1 (2004).","journal-title":"J. Inflamm."},{"key":"562_CR28","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2008.01.003","volume":"18","author":"P Allavena","year":"2008","unstructured":"Allavena, P., Garlanda, C., Borrello, M. G., Sica, A. & Mantovani, A. Pathways connecting inflammation and cancer. Curr. Opin. Genet. Dev. 18, 3\u201310 (2008).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"562_CR29","volume":"9","author":"DS Forcey","year":"2014","unstructured":"Forcey, D. S. et al. Chlamydia detection during the menstrual cycle: a cross-sectional study of women attending a sexual health service. PLoS ONE 9, e85263 (2014).","journal-title":"PLoS ONE"},{"key":"562_CR30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/molehr\/gah144","volume":"11","author":"M von Wolff","year":"2005","unstructured":"von Wolff, M., Wang, X., Gabius, H. J. & Strowitzki, T. Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation. Mol. Hum. Reprod. 11, 189\u2013194 (2005).","journal-title":"Mol. Hum. Reprod."},{"key":"562_CR31","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.4052\/tigg.1737.1SE","volume":"30","author":"J Nio-Kobayashi","year":"2018","unstructured":"Nio-Kobayashi, J. Histological mapping and subtype-specific functions of galectins in health and disease. Trends Glycosci. Glycotechnol. 30, E89\u2013SE96 (2018). This review summarizes current knowledge on the cellular and tissue localization of different members of the galectin family, including regulation of galectin expression within the female genital tract.","journal-title":"Trends Glycosci. Glycotechnol."},{"key":"562_CR32","doi-asserted-by":"crossref","first-page":"E6000","DOI":"10.1073\/pnas.1802188115","volume":"115","author":"AL Lujan","year":"2018","unstructured":"Lujan, A. L. et al. Glycosylation-dependent galectin\u2013receptor interactions promote Chlamydia trachomatis infection. Proc. Natl Acad. Sci. USA 115, E6000\u2013E6009 (2018). This study demonstrates, using in vitro and in vivo approaches, the role of Gal-1 in modulating C. trachomatis invasion of cervical epithelial cells by bridging bacterial glycans and N-glycosylated host cell receptors.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR33","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1128\/AAC.46.12.3869-3876.2002","volume":"46","author":"F Dromer","year":"2002","unstructured":"Dromer, F. et al. Synthetic analogues of beta-1,2 oligomannosides prevent intestinal colonization by the pathogenic yeast Candida albicans. Antimicrob. Agents Chemother. 46, 3869\u20133876 (2002).","journal-title":"Antimicrob. Agents Chemother."},{"key":"562_CR34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11904-019-00433-w","volume":"16","author":"F Colomb","year":"2019","unstructured":"Colomb, F., Giron, L., Trbojevic-Akmacic, I., Lauc, G. & Abdel-Mohsen, M. Breaking the glyco-code of HIV persistence and immunopathogenesis. Curr. HIV\/AIDS Rep. 16, 151\u2013168 (2019).","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"562_CR35","unstructured":"Varki, A. et al. Essentials of Glycobiology 3rd edn (Cold Spring Harbor Laboratory Press, 2017)."},{"key":"562_CR36","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nri2417","volume":"8","author":"JD Marth","year":"2008","unstructured":"Marth, J. D. & Grewal, P. K. Mammalian glycosylation in immunity. Nat. Rev. Immunol. 8, 874\u2013887 (2008).","journal-title":"Nat. Rev. Immunol."},{"key":"562_CR37","doi-asserted-by":"crossref","unstructured":"Johannes, L., Jacob, R. &Leffler, H. Galectins at a glance. J. Cell Sci.131, (2018).","DOI":"10.1242\/jcs.208884"},{"key":"562_CR38","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-981-15-1580-4_7","volume":"1204","author":"GR Vasta","year":"2020","unstructured":"Vasta, G. R. Galectins in host\u2013pathogen interactions: structural, functional and evolutionary aspects. Adv. Exp. Med. Biol. 1204, 169\u2013196 (2020).","journal-title":"Adv. Exp. Med. Biol."},{"key":"562_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06492.x","volume":"1253","author":"GA Rabinovich","year":"2012","unstructured":"Rabinovich, G. A., van Kooyk, Y. & Cobb, B. A. Glycobiology of immune responses. Ann. N. Y. Acad. Sci. 1253, 1\u201315 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"562_CR40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev-immunol-041015-055402","volume":"34","author":"S Thiemann","year":"2016","unstructured":"Thiemann, S. & Baum, L. G. Galectins and immune responses-just how do they do those things they do? Annu. Rev. Immunol. 34, 243\u2013264 (2016). This article summarizes the essential role of galectins in innate and adaptive immune responses.","journal-title":"Annu. Rev. Immunol."},{"key":"562_CR41","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tibs.2016.11.003","volume":"42","author":"JP Cerliani","year":"2017","unstructured":"Cerliani, J. P., Blidner, A. G., Toscano, M. A., Croci, D. O. & Rabinovich, G. A. Translating the \u2018sugar code\u2019 into immune and vascular signaling programs. Trends Biochem. Sci. 42, 255\u2013273 (2017).","journal-title":"Trends Biochem. Sci."},{"key":"562_CR42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1096\/fj.201901817R","volume":"34","author":"SM Maller","year":"2020","unstructured":"Maller, S. M. et al. An adipose tissue galectin controls endothelial cell function via preferential recognition of 3-fucosylated glycans. FASEB J. 34, 735\u2013753 (2020).","journal-title":"FASEB J."},{"key":"562_CR43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-1-4614-0106-3_2","volume":"946","author":"GR Vasta","year":"2012","unstructured":"Vasta, G. R. In Current topics in innate immunity II. Adv. Exp. Med. Biol. 946, 21\u201336 (2012).","journal-title":"Adv. Exp. Med. Biol."},{"key":"562_CR44","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semcdb.2018.02.022","volume":"83","author":"SJ Popa","year":"2018","unstructured":"Popa, S. J., Stewart, S. E. & Moreau, K. Unconventional secretion of annexins and galectins. Semin. Cell Dev. Biol. 83, 42\u201350 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"562_CR45","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/s41590-020-00844-7","volume":"22","author":"A Russo","year":"2021","unstructured":"Russo, A. et al. Intracellular immune sensing promotes inflammation via gasdermin D-driven release of a lectin alarmin. Nat. Immunol. 22, 154\u2013165 (2021). This study summarizes an emerging mechanism of Gal-1 secretion upon intracellular lipopolysaccharide sensing involving non-canonical inflammasome activation and induction of pyroptotic or necroptotic cell death.","journal-title":"Nat. Immunol."},{"key":"562_CR46","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41585-019-0183-5","volume":"16","author":"N Mart\u00ednez-Bosch","year":"2019","unstructured":"Mart\u00ednez-Bosch, N. et al. Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities. Nat. Rev. Urol. 16, 433\u2013445 (2019).","journal-title":"Nat. Rev. Urol."},{"key":"562_CR47","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2009.12.008","volume":"139","author":"JW Dennis","year":"2009","unstructured":"Dennis, J. W., Nabi, I. R. & Demetriou, M. Metabolism, cell surface organization, and disease. Cell 139, 1229\u20131241 (2009).","journal-title":"Cell"},{"key":"562_CR48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","volume":"156","author":"DO Croci","year":"2014","unstructured":"Croci, D. O. et al. Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors. Cell 156, 744\u2013758 (2014).","journal-title":"Cell"},{"key":"562_CR49","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20182041","volume":"217","author":"MR Girotti","year":"2020","unstructured":"Girotti, M. R., Salatino, M., Dalotto-Moreno, T. & Rabinovich, G. A. Sweetening the hallmarks of cancer: galectins as multifunctional mediators of tumor progression. J. Exp. Med. 217, e20182041 (2020).","journal-title":"J. Exp. Med."},{"key":"562_CR50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1749-6632.2011.06386.x","volume":"1253","author":"F-T Liu","year":"2012","unstructured":"Liu, F.-T., Yang, R.-Y. & Hsu, D. K. Galectins in acute and chronic inflammation. Ann. N. Y. Acad. Sci. 1253, 80\u201391 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"562_CR51","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1242\/jcs.151159","volume":"128","author":"IR Nabi","year":"2015","unstructured":"Nabi, I. R., Shankar, J. & Dennis, J. W. The galectin lattice at a glance. J. Cell Sci. 128, 2213\u20132219 (2015).","journal-title":"J. Cell Sci."},{"key":"562_CR52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12929-021-00713-x","volume":"28","author":"MH Hong","year":"2021","unstructured":"Hong, M. H. et al. Intracellular galectins sense cytosolically exposed glycans as danger and mediate cellular responses. J. Biomed. Sci. 28, 16 (2021).","journal-title":"J. Biomed. Sci."},{"key":"562_CR53","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.4049\/jimmunol.1700579","volume":"199","author":"RC Davicino","year":"2017","unstructured":"Davicino, R. C. et al. Galectin-1-driven tolerogenic programs aggravate Yersinia enterocolitica infection by repressing antibacterial immunity. J. Immunol. 199, 1382\u20131392 (2017).","journal-title":"J. Immunol."},{"key":"562_CR54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/femspd\/ftx063","volume":"75","author":"TD Mubaiwa","year":"2017","unstructured":"Mubaiwa, T. D. et al. The sweet side of the pathogenic Neisseria: the role of glycan interactions in colonisation and disease. Pathog. Dis. 75, 1\u20139 (2017).","journal-title":"Pathog. Dis."},{"key":"562_CR55","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1046\/j.1462-5822.2002.00219.x","volume":"4","author":"CM John","year":"2002","unstructured":"John, C. M. et al. Galectin-3 binds lactosaminylated lipooligosaccharides from Neisseria gonorrhoeae and is selectively expressed by mucosal epithelial cells that are infected. Cell. Microbiol. 4, 649\u2013662 (2002). This study reports the role of endogenous Gal-3 in binding bacterial lipo-oligosaccharides from Neisseria gonorrhoeae.","journal-title":"Cell. Microbiol."},{"key":"562_CR56","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1074\/jbc.M115.651497","volume":"291","author":"RN Fichorova","year":"2016","unstructured":"Fichorova, R. N. et al. Trichomonas vaginalis lipophosphoglycan exploits binding to galectin-1 and -3 to modulate epithelial immunity. J. Biol. Chem. 291, 998\u20131013 (2016). This paper shows the ability of Gal-1 and Gal-3 to bind and modulate immune responses upon infection with the parasite T. vaginalis.","journal-title":"J. Biol. Chem."},{"key":"562_CR57","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s00705-009-0351-7","volume":"154","author":"RD King","year":"2009","unstructured":"King, R. D., Lubinski, J. M. & Friedman, H. M. Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3. Arch. Virol. 154, 609\u2013618 (2009).","journal-title":"Arch. Virol."},{"key":"562_CR58","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1128\/JVI.00166-13","volume":"87","author":"AM Woodward","year":"2013","unstructured":"Woodward, A. M., Mauris, J. & Argueso, P. Binding of transmembrane mucins to galectin-3 limits herpesvirus 1 infection of human corneal keratinocytes. J. Virol. 87, 5841\u20135847 (2013).","journal-title":"J. Virol."},{"key":"562_CR59","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/glycob\/cwu064","volume":"24","author":"S-F Wang","year":"2014","unstructured":"Wang, S.-F. et al. Galectin-3 promotes HIV-1 budding via association with Alix and Gag p6. Glycobiology 24, 1022\u20131035 (2014). This study illustrates the role of endogenous galectin-3 in facilitating HIV-1 budding and infection by promoting the association of ALG-2-interacting protein X (Alix) with viral Gag p6.","journal-title":"Glycobiology"},{"key":"562_CR60","doi-asserted-by":"crossref","first-page":"14270","DOI":"10.1073\/pnas.1111415108","volume":"108","author":"A Esteban","year":"2011","unstructured":"Esteban, A. et al. Fungal recognition is mediated by the association of dectin-1 and galectin-3 in macrophages. Proc. Natl Acad. Sci. USA 108, 14270\u201314275 (2011). This article reports the cross-talk between the C-type lectin dectin-1 and Gal-3 in regulating recognition and macrophage function in response to fungal infection.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR61","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.4049\/jimmunol.177.7.4718","volume":"177","author":"L Kohatsu","year":"2006","unstructured":"Kohatsu, L., Hsu, D. K., Jegalian, A. G., Liu, F.-T. & Baum, L. G. Galectin-3 induces death of Candida species expressing specific \u03b2-1,2-linked mannans. J. Immunol. 177, 4718\u20134726 (2006).","journal-title":"J. Immunol."},{"key":"562_CR62","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.4049\/jimmunol.177.7.4679","volume":"177","author":"T Jouault","year":"2006","unstructured":"Jouault, T. et al. Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J. Immunol. 177, 4679\u20134687 (2006).","journal-title":"J. Immunol."},{"key":"562_CR63","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/cmi.12103","volume":"15","author":"JR Linden","year":"2013","unstructured":"Linden, J. R., Kunkel, D., Laforce-Nesbitt, S. S. & Bliss, J. M. The role of galectin-3 in phagocytosis of Candida albicans and Candida parapsilosis by human neutrophils. Cell. Microbiol. 15, 1127\u20131142 (2013).","journal-title":"Cell. Microbiol."},{"key":"562_CR64","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3109\/13693786.2013.770607","volume":"51","author":"JR Linden","year":"2013","unstructured":"Linden, J. R., De Paepe, M. E., Laforce-Nesbitt, S. S. & Bliss, J. M. Galectin-3 plays an important role in protection against disseminated candidiasis. Med. Mycol. 51, 641\u2013651 (2013).","journal-title":"Med. Mycol."},{"key":"562_CR65","first-page":"48","volume":"8","author":"SY Wu","year":"2017","unstructured":"Wu, S. Y. et al. Cell intrinsic galectin-3 attenuates neutrophil ROS-dependent killing of Candida by modulating CR3 downstream syk activation. Front. Immunol. 8, 48 (2017).","journal-title":"Front. Immunol."},{"key":"562_CR66","doi-asserted-by":"crossref","first-page":"11742","DOI":"10.1128\/JVI.05351-11","volume":"85","author":"C St-Pierre","year":"2011","unstructured":"St-Pierre, C. et al. Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4. J. Virol. 85, 11742\u201311751 (2011). This work demonstrates that HIV-1 exploits Gal-1 to enhance gp120\u2013CD4 interactions, thereby promoting virus attachment and infection.","journal-title":"J. Virol."},{"key":"562_CR67","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.4049\/jimmunol.174.7.4120","volume":"174","author":"M Ouellet","year":"2005","unstructured":"Ouellet, M. et al. Galectin-1 acts as a soluble host factor that promotes HIV-1 infectivity through stabilization of virus attachment to host cells. J. Immunol. 174, 4120\u20134126 (2005).","journal-title":"J. Immunol."},{"key":"562_CR68","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/039463200501800402","volume":"18","author":"MI Gonzalez","year":"2005","unstructured":"Gonzalez, M. I. et al. Regulated expression of galectin-1 after in vitro productive infection with herpes simplex virus type 1: implications for T cell apoptosis. Int. J. Immunopathol. Pharmacol. 18, 615\u2013623 (2005).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"562_CR69","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.4049\/jimmunol.1103063","volume":"188","author":"NK Rajasagi","year":"2012","unstructured":"Rajasagi, N. K. et al. Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J. Immunol. 188, 4631\u20134643 (2012).","journal-title":"J. Immunol."},{"key":"562_CR70","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.3390\/ijms21082910","volume":"21","author":"WH Wang","year":"2020","unstructured":"Wang, W. H. et al. Amino acid deletions in p6Gag domain of HIV-1 CRF07_BC ameliorate galectin-3 mediated enhancement in viral budding. Int. J. Mol. Sci. 21, 2910 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"562_CR71","doi-asserted-by":"crossref","first-page":"10650","DOI":"10.1073\/pnas.1017954108","volume":"108","author":"S Bi","year":"2011","unstructured":"Bi, S., Hong, P. W., Lee, B. & Baum, L. G. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc. Natl Acad. Sci. USA 108, 10650\u201310655 (2011). This study highlights a mechanism that regulates cell surface redox status mediated by Gal-9\u2013glycoprotein lattices that regulate distinct T cell functions.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR72","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/aid.2014.0004","volume":"30","author":"R Tandon","year":"2014","unstructured":"Tandon, R. et al. Galectin-9 is rapidly released during acute HIV-1 infection and remains sustained at high levels despite viral suppression even in elite controllers. AIDS Res. Hum. Retroviruses 30, 654\u2013664 (2014).","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"562_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1005677","volume":"12","author":"M Abdel-Mohsen","year":"2016","unstructured":"Abdel-Mohsen, M. et al. Human galectin-9 is a potent mediator of HIV transcription and reactivation. PLoS Pathog. 12, 1\u201328 (2016). This study shows the ability of Gal-9 to revert HIV latency, suggesting its role in controlling HIV transcription and viral production during therapy.","journal-title":"PLoS Pathog."},{"key":"562_CR74","doi-asserted-by":"crossref","first-page":"548","DOI":"10.2471\/BLT.18.228486","volume":"97","author":"J Rowley","year":"2019","unstructured":"Rowley, J. et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis. Bull. World Health Organ. 97, 548\u2013562 (2019).","journal-title":"Bull. World Health Organ."},{"key":"562_CR75","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1098-2795(199710)48:2<261::AID-MRD14>3.0.CO;2-0","volume":"48","author":"YS Choe","year":"1997","unstructured":"Choe, Y. S. et al. Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation. Mol. Reprod. Dev. 48, 261\u2013266 (1997).","journal-title":"Mol. Reprod. Dev."},{"key":"562_CR76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12565-016-0366-6","volume":"92","author":"J Nio-Kobayashi","year":"2017","unstructured":"Nio-Kobayashi, J. Tissue- and cell-specific localization of galectins, \u03b2-galactose-binding animal lectins, and their potential functions in health and disease. Anat. Sci. Int. 92, 25\u201336 (2017).","journal-title":"Anat. Sci. Int."},{"key":"562_CR77","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347, 1260419 (2015).","journal-title":"Science"},{"key":"562_CR78","doi-asserted-by":"crossref","first-page":"649940","DOI":"10.3389\/fcimb.2021.649940","volume":"11","author":"RN Fichorova","year":"2021","unstructured":"Fichorova, R. N. Protozoan-viral-bacterial co-infections alter galectin levels and associated immunity mediators in the female genital tract. Front. Cell Infect. Microbiol. 11, 649940 (2021). This article provides clinical and experimental evidence showing dysregulation of galectin networks by co-infections with bacteria, virus, fungi and parasites.","journal-title":"Front. Cell Infect. Microbiol."},{"key":"562_CR79","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jri.2009.08.007","volume":"83","author":"RN Fichorova","year":"2009","unstructured":"Fichorova, R. N. Impact of T. vaginalis infection on innate immune responses and reproductive outcome. J. Reprod. Immunol. 83, 185\u2013189 (2009).","journal-title":"J. Reprod. Immunol."},{"key":"562_CR80","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/1040841X.2015.1105782","volume":"42","author":"T Edwards","year":"2016","unstructured":"Edwards, T., Burke, P., Smalley, H. & Hobbs, G. Trichomonas vaginalis: clinical relevance, pathogenicity and diagnosis. Crit. Rev. Microbiol. 42, 406\u2013417 (2016).","journal-title":"Crit. Rev. Microbiol."},{"key":"562_CR81","doi-asserted-by":"publisher","unstructured":"Van Gerwen, O. T. & Muzny, C. A. Recent advances in the epidemiology, diagnosis, and management of Trichomonas vaginalis infection. F1000 Res. https:\/\/doi.org\/10.12688\/f1000research.19972.1 (2019).","DOI":"10.12688\/f1000research.19972.1"},{"key":"562_CR82","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/sti.76.4.248","volume":"76","author":"FJ Bowden","year":"2000","unstructured":"Bowden, F. J. & Garnett, G. P. Trichomonas vaginalis epidemiology: parameterising and analysing a model of treatment interventions. Sex. Transm. Infect. 76, 248\u2013256 (2000).","journal-title":"Sex. Transm. Infect."},{"key":"562_CR83","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/sj.jp.7210714","volume":"22","author":"LM Smith","year":"2002","unstructured":"Smith, L. M., Wang, M., Zangwill, K. & Yeh, S. Trichomonas vaginalis infection in a premature newborn. J. Perinatol. 22, 502\u2013503 (2002).","journal-title":"J. Perinatol."},{"key":"562_CR84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/028418600431003","volume":"39","author":"M Viikki","year":"2000","unstructured":"Viikki, M., Pukkala, E., Nieminen, P. & Hakama, M. Gynaecological infections as risk determinants of subsequent cervical neoplasia. Acta Oncol. 39, 71\u201375 (2000).","journal-title":"Acta Oncol."},{"key":"562_CR85","doi-asserted-by":"crossref","first-page":"8179","DOI":"10.1073\/pnas.1321884111","volume":"111","author":"O Twu","year":"2014","unstructured":"Twu, O. et al. Trichomonas vaginalis homolog of macrophage migration inhibitory factor induces prostate cell growth, invasiveness, and inflammatory responses. Proc. Natl Acad. Sci. USA 111, 8179\u20138184 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"562_CR86","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0140-6736(05)78181-2","volume":"351","author":"F Sorvillo","year":"1998","unstructured":"Sorvillo, F. & Kerndt, P. Trichomonas vaginalis and amplification of HIV-1 transmission. Lancet 351, 213\u2013214 (1998).","journal-title":"Lancet"},{"key":"562_CR87","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/OLQ.0000000000000756","volume":"45","author":"CM Price","year":"2018","unstructured":"Price, C. M. et al. Prevalence and detection of Trichomonas vaginalis in HIV-infected pregnant women. Sex. Transm. Dis. 45, 332\u2013336 (2018).","journal-title":"Sex. Transm. Dis."},{"key":"562_CR88","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/sextrans-2012-051005","volume":"89","author":"P Kissinger","year":"2013","unstructured":"Kissinger, P. & Adamski, A. Trichomoniasis and HIV interactions: a review. Sex. Transm. Infect. 89, 426\u2013433 (2013).","journal-title":"Sex. Transm. Infect."},{"key":"562_CR89","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1128\/CMR.11.2.300","volume":"11","author":"D Petrin","year":"1998","unstructured":"Petrin, D., Delgaty, K., Bhatt, R. & Garber, G. Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol. Rev. 11, 300\u2013317 (1998).","journal-title":"Clin. Microbiol. Rev."},{"key":"562_CR90","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1128\/EC.4.11.1951-1958.2005","volume":"4","author":"FD Bastida-Corcuera","year":"2005","unstructured":"Bastida-Corcuera, F. D., Okumura, C. Y., Colocoussi, A. & Johnson, P. J. Trichomonas vaginalis lipophosphoglycan mutants have reduced adherence and cytotoxicity to human ectocervical cells. Eukaryot. Cell 4, 1951\u20131958 (2005).","journal-title":"Eukaryot. Cell"},{"key":"562_CR91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10719-008-9157-1","volume":"26","author":"BN Singh","year":"2009","unstructured":"Singh, B. N. et al. Structural details and composition of Trichomonas vaginalis lipophosphoglycan in relevance to the epithelial immune function. Glycoconj. J. 26, 3\u201317 (2009).","journal-title":"Glycoconj. J."},{"key":"562_CR92","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1111\/j.1462-5822.2008.01190.x","volume":"10","author":"CYM Okumura","year":"2008","unstructured":"Okumura, C. Y. M., Baum, L. G. & Johnson, P. J. Galectin-1 on cervical epithelial cells is a receptor for the sexually transmitted human parasite Trichomonas vaginalis. Cell. Microbiol. 10, 2078\u20132090 (2008). This study reports the regulated expression of Gal-1 by human cervical epithelial cells, its binding to T. vaginalis lipophosphoglycan and its role in enhancing parasite recognition and invasion.","journal-title":"Cell. Microbiol."},{"key":"562_CR93","doi-asserted-by":"crossref","first-page":"40494","DOI":"10.1074\/jbc.M111.280578","volume":"286","author":"CM Ryan","year":"2011","unstructured":"Ryan, C. M., Mehlert, A., Richardson, J. M., Ferguson, M. A. J. & Johnson, P. J. Chemical structure of Trichomonas vaginalis surface lipoglycan: a role for short galactose (\u03b21-4\/3) N-acetylglucosamine repeats in host cell interaction. J. Biol. Chem. 286, 40494\u201340508 (2011).","journal-title":"J. Biol. Chem."},{"key":"562_CR94","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrmicro.2016.30","volume":"14","author":"C Elwell","year":"2016","unstructured":"Elwell, C., Mirrashidi, K. & Engel, J. Chlamydia cell biology and pathogenesis. Nat. Rev. Microbiol. 14, 385\u2013400 (2016).","journal-title":"Nat. Rev. Microbiol."},{"key":"562_CR95","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/CMR.00035-15","volume":"28","author":"S Menon","year":"2015","unstructured":"Menon, S. et al. Human and pathogen factors associated with Chlamydia trachomatis-related infertility in women. Clin. Microbiol. Rev. 28, 969\u2013985 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"562_CR96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2019.00756","volume":"10","author":"ME Panzetta","year":"2019","unstructured":"Panzetta, M. E. et al. Ptr\/CTL0175 is required for the efficient recovery of Chlamydia trachomatis from stress induced by gamma-interferon. Front. Microbiol. 10, 1\u201318 (2019).","journal-title":"Front. Microbiol."},{"key":"562_CR97","volume":"95","author":"H Zhu","year":"2016","unstructured":"Zhu, H., Shen, Z., Luo, H., Zhang, W. & Zhu, X. Chlamydia trachomatis infection-associated risk of cervical cancer: a meta-analysis. Medicine 95, e3077 (2016).","journal-title":"Medicine"},{"key":"562_CR98","doi-asserted-by":"crossref","first-page":"a010256","DOI":"10.1101\/cshperspect.a010256","volume":"3","author":"RJ Bastidas","year":"2013","unstructured":"Bastidas, R. J., Elwell, C. A., Engel, J. N. & Valdivia, R. H. Chlamydial intracellular survival strategies. Cold Spring Harb. Perspect. Med. 3, a010256 (2013).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"562_CR99","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12325","author":"MT Damiani","year":"2014","unstructured":"Damiani, M. T., Tudela, J. G. & Capmany, A. Targeting eukaryotic Rab proteins: a smart strategy for chlamydial survival and replication. Cell. Microbiol. https:\/\/doi.org\/10.1111\/cmi.12325 (2014).","journal-title":"Cell. Microbiol."},{"key":"562_CR100","first-page":"1","volume":"20","author":"JG Tudela","year":"2019","unstructured":"Tudela, J. G. et al. Rab39a and Rab39b display different intracellular distribution and function in sphingolipids and phospholipids transport. Int. J. Mol. Sci. 20, 1\u201317 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"562_CR101","first-page":"35","volume":"412","author":"MM Coss\u00e9","year":"2016","unstructured":"Coss\u00e9, M. M., Hayward, R. D. & Subtil, A. One face of Chlamydia trachomatis: the infectious elementary body. Curr. Top. Microbiol. Immunol. 412, 35\u201358 (2016).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"562_CR102","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1128\/IAI.66.4.1607-1612.1998","volume":"66","author":"AF Swanson","year":"1998","unstructured":"Swanson, A. F., Ezekowitz, R. A. B., Lee, A. & Kuo, C. C. Human mannose-binding protein inhibits infection of HeLa cells by Chlamydia trachomatis. Infect. Immun. 66, 1607\u20131612 (1998).","journal-title":"Infect. Immun."},{"key":"562_CR103","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/IAI.69.2.968-976.2001","volume":"69","author":"M Taraktchoglou","year":"2001","unstructured":"Taraktchoglou, M., Pacey, A. A., Turnbull, J. E. & Eley, A. Infectivity of Chlamydia trachomatis serovar LGV but not E is dependent on host cell heparan sulfate. Infect. Immun. 69, 968\u2013976 (2001).","journal-title":"Infect. Immun."},{"key":"562_CR104","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1046\/j.1365-2958.2002.02841.x","volume":"43","author":"FD Menozzi","year":"2002","unstructured":"Menozzi, F. D. et al. Enhanced bacterial virulence through exploitation of host glycosaminoglycans. Mol. Microbiol. 43, 1379\u20131386 (2002).","journal-title":"Mol. Microbiol."},{"key":"562_CR105","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1093\/glycob\/cws106","volume":"22","author":"V Tiwari","year":"2012","unstructured":"Tiwari, V., Maus, E., Sigar, I. M., Ramsey, K. H. & Shukla, D. Role of heparan sulfate in sexually transmitted infections. Glycobiology 22, 1402\u20131412 (2012).","journal-title":"Glycobiology"},{"key":"562_CR106","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1086\/374056","volume":"187","author":"EJ Beswick","year":"2003","unstructured":"Beswick, E. J., Travelstead, A. & Cooper, M. D. Comparative studies of glycosaminoglycan involvement in Chlamydia pneumoniae and C. trachomatis invasion of host cells. J. Infect. Dis. 187, 1291\u20131300 (2003).","journal-title":"J. Infect. Dis."},{"key":"562_CR107","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1099\/jmm.0.2008\/001305-0","volume":"57","author":"S Fadel","year":"2008","unstructured":"Fadel, S. & Eley, A. Differential glycosaminoglycan binding of Chlamydia trachomatis OmcB protein from serovars E and LGV. J. Med. Microbiol. 57, 1058\u20131061 (2008).","journal-title":"J. Med. Microbiol."},{"key":"562_CR108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1000021","volume":"4","author":"CA Elwell","year":"2008","unstructured":"Elwell, C. A., Ceesay, A., Jung, H. K., Kalman, D. & Engel, J. N. RNA interference screen identifies Abl kinase and PDGFR signaling in Chlamydia trachomatis entry. PLoS Pathog. 4, 1\u201315 (2008).","journal-title":"PLoS Pathog."},{"key":"562_CR109","volume":"7","author":"JH Kim","year":"2011","unstructured":"Kim, J. H., Jiang, S., Elwell, C. A. & Engel, J. N. Chlamydia trachomatis co-opts the FGF2 signaling pathway to enhance infection. PLoS Pathog. 7, e1002285 (2011).","journal-title":"PLoS Pathog."},{"key":"562_CR110","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/cmi.12549","volume":"18","author":"S Stallmann","year":"2016","unstructured":"Stallmann, S. & Hegemann, J. H. The Chlamydia trachomatis Ctad1 invasin exploits the human integrin \u03b21 receptor for host cell entry. Cell. Microbiol. 18, 761\u2013775 (2016).","journal-title":"Cell. Microbiol."},{"key":"562_CR111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2015.00096","volume":"5","author":"JE Messinger","year":"2015","unstructured":"Messinger, J. E., Nelton, E., Feeney, C. & Gondek, D. C. Chlamydia infection across host species boundaries promotes distinct sets of transcribed anti-apoptotic factors. Front. Cell. Infect. Microbiol. 5, 1\u20139 (2015).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"562_CR112","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12941-021-00465-4","volume":"20","author":"I Benamri","year":"2021","unstructured":"Benamri, I., Azzouzi, M., Sanak, K., Moussa, A. & Moussa, F. An overview of genes and mutations associated with Chlamydiae species\u2019 resistance to antibiotics. Ann. Clin. Microbiol. Antimicrob. 20, 59 (2021).","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"562_CR113","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/sj.eye.6700112","volume":"16","author":"JS Lee","year":"2002","unstructured":"Lee, J. S., Choi, H. Y., Lee, J. E., Lee, S. H. & Oum, B. S. Gonococcal keratoconjunctivitis in adults. Eye 16, 646\u2013649 (2002).","journal-title":"Eye"},{"key":"562_CR114","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/OLQ.0000000000000384","volume":"43","author":"CS Danby","year":"2016","unstructured":"Danby, C. S. et al. Patterns of extragenital Chlamydia and Gonorrhea in women and men who have sex with men reporting a history of receptive anal intercourse. Sex. Transm. Dis. 43, 105\u2013109 (2016).","journal-title":"Sex. Transm. Dis."},{"key":"562_CR115","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3389\/fimmu.2018.03187","volume":"9","author":"A Lovett","year":"2018","unstructured":"Lovett, A. & Duncan, J. A. Human immune responses and the natural history of Neisseria gonorrhoeae infection. Front. Immunol. 9, 3187 (2018).","journal-title":"Front. Immunol."},{"key":"562_CR116","first-page":"931","volume":"86","author":"MT Mayor","year":"2012","unstructured":"Mayor, M. T., Roett, M. A. & Uduhiri, K. A. Diagnosis and management of gonococcal infections. Am. Fam. Phys. 86, 931\u2013938 (2012).","journal-title":"Am. Fam. Phys."},{"key":"562_CR117","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.rdc.2009.03.001","volume":"35","author":"I Garc\u00eda-De La Torre","year":"2009","unstructured":"Garc\u00eda-De La Torre, I. & Nava-Zavala, A. Gonococcal and nongonococcal arthritis. Rheum. Dis. Clin. North Am. 35, 63\u201373 (2009).","journal-title":"Rheum. Dis. Clin. North Am."},{"key":"562_CR118","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s15010-013-0541-9","volume":"42","author":"A Ramos","year":"2014","unstructured":"Ramos, A. et al. Gonococcal endocarditis: a case report and review of the literature. Infection 42, 425\u2013428 (2014).","journal-title":"Infection"},{"key":"562_CR119","doi-asserted-by":"crossref","first-page":"e00534","DOI":"10.1128\/mBio.00534-17","volume":"8","author":"CP Churchward","year":"2017","unstructured":"Churchward, C. P., Alany, R. G., Kirk, R. S., Walker, A. J. & Snyder, L. A. S. Prevention of ophthalmianeonatorum caused by Neisseria gonorrhoeae using a fatty acid-based formulation. mBio 8, e00534\u201317 (2017).","journal-title":"mBio"},{"key":"562_CR120","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/sextrans-2018-053793","volume":"95","author":"S Tuddenham","year":"2019","unstructured":"Tuddenham, S. et al. Gonorrhoea and chlamydia in persons with HIV: number needed to screen. Sex. Transm. Infect. 95, 322\u2013327 (2019).","journal-title":"Sex. Transm. Infect."},{"key":"562_CR121","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00002030-200303070-00019","volume":"17","author":"A Chen","year":"2003","unstructured":"Chen, A., Boulton, I. C., Pongoski, J., Cochrane, A. & Gray-Owen, S. D. Induction of HIV-1 long terminal repeat-mediated transcription by Neisseria gonorrhoeae. AIDS 17, 625\u2013628 (2003).","journal-title":"AIDS"},{"key":"562_CR122","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1046\/j.1365-2958.1999.01416.x","volume":"32","author":"X Nassif","year":"1999","unstructured":"Nassif, X., Pujol, C., Morand, P. & Eug\u00e8ne, E. Interactions of pathogenic Neisseria with host cells. Is it possible to assemble the puzzle? Mol. Microbiol. 32, 1124\u20131132 (1999).","journal-title":"Mol. Microbiol."},{"key":"562_CR123","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1462-5822.2001.00095.x","volume":"3","author":"H K\u00e4llstr\u00f6m","year":"2001","unstructured":"K\u00e4llstr\u00f6m, H. et al. Attachment of Neisseria gonorrhoeae to the cellular pilus receptor CD46: identification of domains important for bacterial adherence. Cell. Microbiol. 3, 133\u2013143 (2001).","journal-title":"Cell. Microbiol."},{"key":"562_CR124","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/j.1460-2075.1993.tb05697.x","volume":"12","author":"EM Kupsch","year":"1993","unstructured":"Kupsch, E. M., Knepper, B., Kuroki, T., Heuer, I. & Meyer, T. F. Variable opacity (Opa) outer membrane proteins account for the cell tropisms displayed by Neisseria gonorrhoeae for human leukocytes and epithelial cells. EMBO J. 12, 641\u2013650 (1993).","journal-title":"EMBO J."},{"key":"562_CR125","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1046\/j.1365-2958.1999.01230.x","volume":"31","author":"FJ Bauer","year":"1999","unstructured":"Bauer, F. J., Rudel, T., Stein, M. & Meyer, T. F. Mutagenesis of the Neisseria gonorrhoeae porin reduces invasion in epithelial cells and enhances phagocyte responsiveness. Mol. Microbiol. 31, 903\u2013913 (1999).","journal-title":"Mol. Microbiol."},{"key":"562_CR126","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1046\/j.1365-2958.1997.6342006.x","volume":"26","author":"SD Gray-Owen","year":"1997","unstructured":"Gray-Owen, S. D., Lorenzen, D. R., Haude, A., Meyer, T. F. & Dehio, C. Differential Opa specificities for CD66 receptors influence tissue interactions and cellular response to Neisseria gonorrhoeae. Mol. Microbiol. 26, 971\u2013980 (1997).","journal-title":"Mol. Microbiol."},{"key":"562_CR127","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1046\/j.1365-2958.1998.01101.x","volume":"30","author":"IM Feavers","year":"1998","unstructured":"Feavers, I. M. & Maiden, M. C. A gonococcal porA pseudogene: implications for understanding the evolution and pathogenicity of Neisseria gonorrhoeae. Mol. Microbiol. 30, 647\u2013656 (1998).","journal-title":"Mol. Microbiol."},{"key":"562_CR128","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/iai.65.3.964-970.1997","volume":"65","author":"TD Duensing","year":"1997","unstructured":"Duensing, T. D. & van Putten, J. P. Vitronectin mediates internalization of Neisseria gonorrhoeae by Chinese hamster ovary cells. Infect. Immun. 65, 964\u2013970 (1997).","journal-title":"Infect. Immun."},{"key":"562_CR129","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1074\/jbc.274.2.1017","volume":"274","author":"CM John","year":"1999","unstructured":"John, C. M., Schneider, H. & Griffiss, J. M. Neisseria gonorrhoeae that infect men have lipooligosaccharides with terminal N-acetyllactosamine repeats. J. Biol. Chem. 274, 1017\u20131025 (1999).","journal-title":"J. Biol. Chem."},{"key":"562_CR130","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1084\/jem.191.6.949","volume":"191","author":"W Song","year":"2000","unstructured":"Song, W., Ma, L., Chen, R. & Stein, D. C. Role of lipooligosaccharide in Opa-independent invasion of Neisseria gonorrhoeae into human epithelial cells. J. Exp. Med. 191, 949\u2013960 (2000).","journal-title":"J. Exp. Med."},{"key":"562_CR131","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.3389\/fimmu.2018.02710","volume":"9","author":"JD Lenz","year":"2018","unstructured":"Lenz, J. D. & Dillard, J. P. Pathogenesis of Neisseria gonorrhoeae and the host defense in ascending infections of human fallopian tube. Front. Immunol. 9, 2710 (2018).","journal-title":"Front. Immunol."},{"key":"562_CR132","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jof6010027","volume":"6","author":"HME Willems","year":"2020","unstructured":"Willems, H. M. E., Ahmed, S. S., Liu, J., Xu, Z. & Peters, B. M. Vulvovaginal candidiasis: a current understanding and burning questions. J. Fungi 6, 27 (2020).","journal-title":"J. Fungi"},{"key":"562_CR133","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3390\/genes9090461","volume":"9","author":"E Ksiezopolska","year":"2018","unstructured":"Ksiezopolska, E. & Gabald\u00f3n, T. Evolutionary emergence of drug resistance in Candida opportunistic pathogens. Genes (Basel) 9, 461 (2018).","journal-title":"Genes (Basel)"},{"key":"562_CR134","doi-asserted-by":"crossref","first-page":"165rv13","DOI":"10.1126\/scitranslmed.3004404","volume":"4","author":"GD Brown","year":"2012","unstructured":"Brown, G. D. et al. Hidden killers: human fungal infections. Sci. Transl. Med. 4, 165rv13 (2012).","journal-title":"Sci. Transl. Med."},{"key":"562_CR135","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12905-019-0748-8","volume":"19","author":"J Yano","year":"2019","unstructured":"Yano, J. et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Women\u2019s. Health 19, 48 (2019).","journal-title":"BMC Women\u2019s. Health"},{"key":"562_CR136","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.tim.2020.05.001","volume":"28","author":"K Min","year":"2020","unstructured":"Min, K., Neiman, A. M. & Konopka, J. B. Fungal pathogens: shape-shifting invaders. Trends Microbiol. 28, 922\u2013933 (2020).","journal-title":"Trends Microbiol."},{"key":"562_CR137","first-page":"1","volume":"10","author":"KJ Looker","year":"2015","unstructured":"Looker, K. J. et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE 10, 1\u201317 (2015).","journal-title":"PLoS ONE"},{"key":"562_CR138","unstructured":"WHO. Progress report on HIV, viral hepatitis and sexually transmitted infections, 2019. Accountability for the global healthsector strategies, 2016\u20132021 (World Health Organization, 2019)."},{"key":"562_CR139","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley, R. J. & Roizman, B. Herpes simplex virus infections. Lancet 357, 1513\u20131518 (2001).","journal-title":"Lancet"},{"key":"562_CR140","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/JVI.02110-06","volume":"81","author":"TP Margolis","year":"2007","unstructured":"Margolis, T. P., Imai, Y., Yang, L., Vallas, V. & Krause, P. R. Herpes simplex virus type 2 (HSV-2) establishes latent infection in a different population of ganglionic neurons than HSV-1: role of latency-associated transcripts. J. Virol. 81, 1872\u20131878 (2007).","journal-title":"J. Virol."},{"key":"562_CR141","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/JVI.72.3.2010-2021.1998","volume":"72","author":"A Dolan","year":"1998","unstructured":"Dolan, A., Jamieson, F. E., Cunningham, C., Barnett, B. C. & McGeoch, D. J. The genome sequence of herpes simplex virus type 2. J. Virol. 72, 2010\u20132021 (1998).","journal-title":"J. Virol."},{"key":"562_CR142","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2007.06.027","volume":"57","author":"M Fatahzadeh","year":"2007","unstructured":"Fatahzadeh, M. & Schwartz, R. A. Human herpes simplex virus infections: epidemiology, pathogenesis, symptomatology, diagnosis, and management. J. Am. Acad. Dermatol. 57, 736\u2013737 (2007).","journal-title":"J. Am. Acad. Dermatol."},{"key":"562_CR143","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1542\/pir.36.2.86","volume":"36","author":"D Ruderfer","year":"2015","unstructured":"Ruderfer, D. & Krilov, L. R. Herpes simplex viruses 1 and 2. Pediatr. Rev. 36, 86\u201390 (2015).","journal-title":"Pediatr. Rev."},{"key":"562_CR144","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/S0140-6736(07)61908-4","volume":"370","author":"R Gupta","year":"2007","unstructured":"Gupta, R., Warren, T. & Wald, A. Genital herpes. Lancet 370, 2127\u20132137 (2007).","journal-title":"Lancet"},{"key":"562_CR145","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/sti.2008.033902","volume":"85","author":"N Ryder","year":"2009","unstructured":"Ryder, N., Jin, F., McNulty, A. M., Grulich, A. E. & Donovan, B. Increasing role of herpes simplex virus type 1 in first-episode anogenital herpes in heterosexual women and younger men who have sex with men, 1992\u20132006. Sex. Transm. Infect. 85, 416\u2013419 (2009).","journal-title":"Sex. Transm. Infect."},{"key":"562_CR146","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1056\/NEJMra0807633","volume":"361","author":"L Corey","year":"2009","unstructured":"Corey, L. & Wald, A. Maternal and neonatal herpes simplex virus infections. N. Engl. J. Med. 361, 1376\u20131385 (2009).","journal-title":"N. Engl. J. Med."},{"key":"562_CR147","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s13311-016-0433-7","volume":"13","author":"MJ Bradshaw","year":"2016","unstructured":"Bradshaw, M. J. & Venkatesan, A. Herpes simplex virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics 13, 493\u2013508 (2016).","journal-title":"Neurotherapeutics"},{"key":"562_CR148","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1542\/peds.2005-1778","volume":"117","author":"RY Kropp","year":"2006","unstructured":"Kropp, R. Y. et al. Neonatal herpes simplex virus infections in Canada: results of a 3-year national prospective study. Pediatrics 117, 1955\u20131962 (2006).","journal-title":"Pediatrics"},{"key":"562_CR149","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1891\/0730-0832.34.5.279","volume":"34","author":"M Kobty","year":"2015","unstructured":"Kobty, M. Herpes simplex virus: beyond the basics. Neonatal Netw. 34, 279\u2013283 (2015).","journal-title":"Neonatal Netw."},{"key":"562_CR150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1136\/sextrans-2013-051453","volume":"90","author":"H Tuokko","year":"2014","unstructured":"Tuokko, H., Bloigu, R. & Hukkanen, V. Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland. Sex. Transm. Infect. 90, 160 (2014).","journal-title":"Sex. Transm. Infect."},{"key":"562_CR151","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.OLQ.0000092387.58746.C7","volume":"30","author":"CM Roberts","year":"2003","unstructured":"Roberts, C. M., Pfister, J. R. & Spear, S. J. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex. Transm. Dis. 30, 797\u2013800 (2003).","journal-title":"Sex. Transm. Dis."},{"key":"562_CR152","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1128\/CMR.00043-15","volume":"29","author":"C Johnston","year":"2016","unstructured":"Johnston, C. & Corey, L. Current concepts for genital herpes simplex virus infection: diagnostics and pathogenesis of genital tract shedding. Clin. Microbiol. Rev. 29, 149\u2013161 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"562_CR153","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-116-3-197","volume":"116","author":"GJ Mertz","year":"1992","unstructured":"Mertz, G. J., Benedetti, J., Ashley, R., Selke, S. A. & Corey, L. Risk factors for the sexual transmission of genital herpes. Ann. Intern. Med. 116, 197\u2013202 (1992).","journal-title":"Ann. Intern. Med."},{"key":"562_CR154","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM199911043411904","volume":"341","author":"AG Langenberg","year":"1999","unstructured":"Langenberg, A. G., Corey, L., Ashley, R. L., Leong, W. P. & Straus, S. E. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. N. Engl. J. Med. 341, 1432\u20131438 (1999).","journal-title":"N. Engl. J. Med."},{"key":"562_CR155","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","volume":"35","author":"L Corey","year":"2004","unstructured":"Corey, L., Wald, A., Celum, C. L. & Quinn, T. C. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J. Acquir. Immune Defic. Syndr. 35, 435\u2013445 (2004).","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"562_CR156","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","volume":"20","author":"EE Freeman","year":"2006","unstructured":"Freeman, E. E. et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 20, 73\u201383 (2006).","journal-title":"AIDS"},{"key":"562_CR157","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.antiviral.2003.12.007","volume":"62","author":"E Trybala","year":"2004","unstructured":"Trybala, E. et al. Structural and functional features of the polycationic peptide required for inhibition of herpes simplex virus invasion of cells. Antivir. Res. 62, 125\u2013134 (2004).","journal-title":"Antivir. Res."},{"key":"562_CR158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126239","volume":"10","author":"P Dogra","year":"2015","unstructured":"Dogra, P. et al. Novel heparan sulfate-binding peptides for blocking herpesvirus entry. PLoS ONE 10, e0126239 (2015).","journal-title":"PLoS ONE"},{"key":"562_CR159","doi-asserted-by":"crossref","first-page":"6429","DOI":"10.1021\/acsnano.8b01616","volume":"12","author":"P Dey","year":"2018","unstructured":"Dey, P. et al. Multivalent flexible nanogels exhibit broad-spectrum antiviral activity by blocking virus entry. ACS Nano 12, 6429\u20136442 (2018).","journal-title":"ACS Nano"},{"key":"562_CR160","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41586-020-2253-5","volume":"582","author":"PJ Tomezsko","year":"2020","unstructured":"Tomezsko, P. J. et al. Determination of RNA structural diversity and its role in HIV-1 RNA splicing. Nature 582, 438\u2013442 (2020).","journal-title":"Nature"},{"key":"562_CR161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14423\/SMJ.0000000000000389","volume":"109","author":"JG Castro","year":"2016","unstructured":"Castro, J. G. & Alcaide, M. L. High rates of STIs in HIV-infected patients attending an STI clinic. South. Med. J. 109, 1\u20134 (2016).","journal-title":"South. Med. J."},{"key":"562_CR162","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00151714","volume":"6","author":"G Morace","year":"1990","unstructured":"Morace, G. et al. Epidemiological and clinical aspects of mycoses in patients with AIDS-related pathologies. Eur. J. Epidemiol. 6, 398\u2013403 (1990).","journal-title":"Eur. J. Epidemiol."},{"key":"562_CR163","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25355","volume":"22","author":"MS Cohen","year":"2019","unstructured":"Cohen, M. S., Council, O. D. & Chen, J. S. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J. Int. AIDS Soc. 22, e25355 (2019).","journal-title":"J. Int. AIDS Soc."},{"key":"562_CR164","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/rmv.1832","volume":"25","author":"S Merani","year":"2015","unstructured":"Merani, S., Chen, W. & Elahi, S. The bitter side of sweet: the role of Galectin-9 in immunopathogenesis of viral infections. Rev. Med. Virol. 25, 175\u2013186 (2015).","journal-title":"Rev. Med. Virol."},{"key":"562_CR165","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1749-6632.2012.06475.x","volume":"1253","author":"S Sato","year":"2012","unstructured":"Sato, S., Ouellet, M., St-Pierre, C. & Tremblay, M. J. Glycans, galectins, and HIV-1 infection. Ann. N. Y. Acad. Sci. 1253, 133\u2013148 (2012).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"562_CR166","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1084\/jem.20031266","volume":"198","author":"RS Veazey","year":"2003","unstructured":"Veazey, R. S. et al. Use of a small molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection or prevent simian-human immunodeficiency virus infection. J. Exp. Med. 198, 1551\u20131562 (2003).","journal-title":"J. Exp. Med."},{"key":"562_CR167","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nm833","volume":"9","author":"RS Veazey","year":"2003","unstructured":"Veazey, R. S. et al. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9, 343\u2013346 (2003).","journal-title":"Nat. Med."},{"key":"562_CR168","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1086\/655661","volume":"202","author":"RS Veazey","year":"2010","unstructured":"Veazey, R. S. et al. Protection of rhesus macaques from vaginal infection by vaginally delivered maraviroc, an inhibitor of HIV-1 entry via the CCR5 co-receptor. J. Infect. Dis. 202, 739\u2013744 (2010).","journal-title":"J. Infect. Dis."},{"key":"562_CR169","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.chom.2018.01.013","volume":"23","author":"MN Anahtar","year":"2018","unstructured":"Anahtar, M. N., Gootenberg, D. B., Mitchell, C. M. & Kwon, D. S. Cervicovaginal microbiota and reproductive health: the virtue of simplicity. Cell Host Microbe 23, 159\u2013168 (2018). This article summarizes current knowledge about cervico-vaginal microbiota, its composition and role in the health of the female genital tract. It also discusses the importance of Lactobacillus colonization, vaginal pH and sex hormones in the eradication of pathogenic bacteria.","journal-title":"Cell Host Microbe"},{"key":"562_CR170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.21101\/cejph.a5142","volume":"27","author":"F Rob","year":"2019","unstructured":"Rob, F. et al. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae co-infections among patients with newly diagnosed syphilis: a single-centre, cross-sectional study. Cent. Eur. J. Public Health 27, 285\u2013291 (2019).","journal-title":"Cent. Eur. J. Public Health"},{"key":"562_CR171","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/00002030-199813000-00019","volume":"12","author":"TE Taha","year":"1998","unstructured":"Taha, T. E. et al. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12, 1699\u20131706 (1998).","journal-title":"AIDS"},{"key":"562_CR172","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00007435-200305000-00006","volume":"30","author":"TL Cherpes","year":"2003","unstructured":"Cherpes, T. L., Meyn, L. A., Krohn, M. A. & Hillier, S. L. Risk factors for infection with herpes simplex virus type 2: role of smoking, douching, uncircumcised males, and vaginal flora. Sex. Transm. Dis. 30, 405\u2013410 (2003).","journal-title":"Sex. Transm. Dis."},{"key":"562_CR173","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nchembio.1525","volume":"10","author":"SR Stowell","year":"2014","unstructured":"Stowell, S. R. et al. Microbial glycan microarrays define key features of host- microbial interactions. Nat. Chem. Biol. 10, 470\u2013476 (2014). This study presents an integrated microbial glycan microarray technology that enables comprehensive analysis of host\u2013microorganism interactions.","journal-title":"Nat. Chem. Biol."},{"key":"562_CR174","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.4049\/jimmunol.1600709","volume":"198","author":"BR Gittens","year":"2017","unstructured":"Gittens, B. R., Bodkin, J. V., Nourshargh, S., Perretti, M. & Cooper, D. Galectin-3: a positive regulator of leukocyte recruitment in the inflamed microcirculation. J. Immunol. 198, 4458\u20134469 (2017).","journal-title":"J. Immunol."},{"key":"562_CR175","doi-asserted-by":"crossref","first-page":"1235681","DOI":"10.1126\/science.1235681","volume":"343","author":"M Dalziel","year":"2014","unstructured":"Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N. & Dwek, R. A. Emerging principles for the therapeutic exploitation of glycosylation. Science 343, 1235681 (2014).","journal-title":"Science"},{"key":"562_CR176","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3390\/ijms19030905","volume":"19","author":"RPM Dings","year":"2018","unstructured":"Dings, R. P. M., Miller, M. C., Griffin, R. J. & Mayo, K. H. Galectins as molecular targets for therapeutic intervention. Int. J. Mol. Sci. 19, 905 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"562_CR177","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fonc.2016.00109","volume":"6","author":"AJ Cagnoni","year":"2016","unstructured":"Cagnoni, A. J., P\u00e9rez S\u00e1ez, J. M., Rabinovich, G. A. & Mari\u00f1o, K. V. Turning-off signaling by siglecs, selectins, and galectins: chemical inhibition of glycan-dependent interactions in cancer. Front. Oncol. 6, 109 (2016).","journal-title":"Front. Oncol."},{"key":"562_CR178","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10456-020-09749-3","volume":"24","author":"JM P\u00e9rez S\u00e1ez","year":"2021","unstructured":"P\u00e9rez S\u00e1ez, J. M. et al. Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities. Angiogenesis 24, 1\u20135 (2021).","journal-title":"Angiogenesis"},{"key":"562_CR179","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04607655 (2021)."},{"key":"562_CR180","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03809052 (2021)."},{"key":"562_CR181","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03832946 (2021)."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41585-021-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-021-00562-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41585-021-00562-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T13:05:42Z","timestamp":1649250342000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41585-021-00562-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":181,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["562"],"URL":"https:\/\/doi.org\/10.1038\/s41585-021-00562-1","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,1]]},"assertion":[{"value":"23 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}